Skip to main content
Top
Published in: European Journal of Clinical Microbiology & Infectious Diseases 1/2013

01-01-2013 | Article

Relatively high serum vitamin D levels do not impair the antibody response to encapsulated bacteria

Authors: E. Peelen, G. Rijkers, A. Meerveld-Eggink, S. Meijvis, M. Vogt, J. W. Cohen Tervaert, R. Hupperts, J. Damoiseaux

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 1/2013

Login to get access

Abstract

Vitamin D skews the immune system towards a more tolerogenic state. Therefore, a relatively high vitamin D status, i.e., within the normal physiological range, might result in a lower antibody response to infection and vaccination. We hypothesized, however, that vitamin D is primarily important in establishing immune homeostasis, implying that a relatively high vitamin D status would not hamper an adequate antibody response against pathogens. Our results show that the vitamin D status did not differ between responders and hypo-responders in patients infected with Streptococcus pneumoniae, as well as patients vaccinated against S. pneumoniae, Neisseria meningitidis type C (MenC), and/or Haemophilus influenzae type b (Hib). Furthermore, specific IgG titers were not associated with the vitamin D status in patients vaccinated against S. pneumoniae and MenC, while there was a weak inverse association in Hib-vaccinated patients. These data indicate that a relatively high vitamin D status does not seem to hamper an adequate antibody response upon infection or vaccination, suggesting that vitamin D, in this setting, is not immunosuppressive.
Literature
1.
go back to reference Smolders J, Damoiseaux J, Menheere P, Hupperts R (2008) Vitamin D as an immune modulator in multiple sclerosis, a review. J Neuroimmunol 194(1–2):7–17PubMedCrossRef Smolders J, Damoiseaux J, Menheere P, Hupperts R (2008) Vitamin D as an immune modulator in multiple sclerosis, a review. J Neuroimmunol 194(1–2):7–17PubMedCrossRef
2.
go back to reference Peelen E, Knippenberg S, Muris AH, Thewissen M, Smolders J, Tervaert JW, Hupperts R, Damoiseaux J (2011) Effects of vitamin D on the peripheral adaptive immune system: a review. Autoimmun Rev 10(12):733–743PubMedCrossRef Peelen E, Knippenberg S, Muris AH, Thewissen M, Smolders J, Tervaert JW, Hupperts R, Damoiseaux J (2011) Effects of vitamin D on the peripheral adaptive immune system: a review. Autoimmun Rev 10(12):733–743PubMedCrossRef
3.
go back to reference Wayse V, Yousafzai A, Mogale K, Filteau S (2004) Association of subclinical vitamin D deficiency with severe acute lower respiratory infection in Indian children under 5 y. Eur J Clin Nutr 58(4):563–567PubMedCrossRef Wayse V, Yousafzai A, Mogale K, Filteau S (2004) Association of subclinical vitamin D deficiency with severe acute lower respiratory infection in Indian children under 5 y. Eur J Clin Nutr 58(4):563–567PubMedCrossRef
4.
go back to reference McNally JD, Leis K, Matheson LA, Karuananyake C, Sankaran K, Rosenberg AM (2009) Vitamin D deficiency in young children with severe acute lower respiratory infection. Pediatr Pulmonol 44(10):981–988PubMedCrossRef McNally JD, Leis K, Matheson LA, Karuananyake C, Sankaran K, Rosenberg AM (2009) Vitamin D deficiency in young children with severe acute lower respiratory infection. Pediatr Pulmonol 44(10):981–988PubMedCrossRef
5.
go back to reference Roth DE, Shah R, Black RE, Baqui AH (2010) Vitamin D status and acute lower respiratory infection in early childhood in Sylhet, Bangladesh. Acta Paediatr 99(3):389–393PubMedCrossRef Roth DE, Shah R, Black RE, Baqui AH (2010) Vitamin D status and acute lower respiratory infection in early childhood in Sylhet, Bangladesh. Acta Paediatr 99(3):389–393PubMedCrossRef
6.
go back to reference Li-Ng M, Aloia JF, Pollack S, Cunha BA, Mikhail M, Yeh J, Berbari N (2009) A randomized controlled trial of vitamin D3 supplementation for the prevention of symptomatic upper respiratory tract infections. Epidemiol Infect 137(10):1396–1404PubMedCrossRef Li-Ng M, Aloia JF, Pollack S, Cunha BA, Mikhail M, Yeh J, Berbari N (2009) A randomized controlled trial of vitamin D3 supplementation for the prevention of symptomatic upper respiratory tract infections. Epidemiol Infect 137(10):1396–1404PubMedCrossRef
7.
go back to reference Laaksi I, Ruohola JP, Mattila V, Auvinen A, Ylikomi T, Pihlajamäki H (2010) Vitamin D supplementation for the prevention of acute respiratory tract infection: a randomized, double-blinded trial among young Finnish men. J Infect Dis 202(5):809–814PubMedCrossRef Laaksi I, Ruohola JP, Mattila V, Auvinen A, Ylikomi T, Pihlajamäki H (2010) Vitamin D supplementation for the prevention of acute respiratory tract infection: a randomized, double-blinded trial among young Finnish men. J Infect Dis 202(5):809–814PubMedCrossRef
8.
go back to reference van Mens SP, Meijvis SC, Endeman H, van Velzen-Blad H, Biesma DH, Grutters JC, Vlaminckx BJ, Rijkers GT (2011) Longitudinal analysis of pneumococcal antibodies during community-acquired pneumonia reveals a much higher involvement of Streptococcus pneumoniae than estimated by conventional methods alone. Clin Vaccine Immunol 18(5):796–801PubMedCrossRef van Mens SP, Meijvis SC, Endeman H, van Velzen-Blad H, Biesma DH, Grutters JC, Vlaminckx BJ, Rijkers GT (2011) Longitudinal analysis of pneumococcal antibodies during community-acquired pneumonia reveals a much higher involvement of Streptococcus pneumoniae than estimated by conventional methods alone. Clin Vaccine Immunol 18(5):796–801PubMedCrossRef
9.
go back to reference Endeman H, Schelfhout V, Voorn GP, van Velzen-Blad H, Grutters JC, Biesma DH (2008) Clinical features predicting failure of pathogen identification in patients with community acquired pneumonia. Scand J Infect Dis 40(9):715–720PubMedCrossRef Endeman H, Schelfhout V, Voorn GP, van Velzen-Blad H, Grutters JC, Biesma DH (2008) Clinical features predicting failure of pathogen identification in patients with community acquired pneumonia. Scand J Infect Dis 40(9):715–720PubMedCrossRef
10.
go back to reference Meerveld-Eggink A, de Weerdt O, de Voer RM, Berbers GA, van Velzen-Blad H, Vlaminckx BJ, Biesma DH, Rijkers GT (2011) Impaired antibody response to conjugated meningococcal serogroup C vaccine in asplenic patients. Eur J Clin Microbiol Infect Dis 30(5):611–618PubMedCrossRef Meerveld-Eggink A, de Weerdt O, de Voer RM, Berbers GA, van Velzen-Blad H, Vlaminckx BJ, Biesma DH, Rijkers GT (2011) Impaired antibody response to conjugated meningococcal serogroup C vaccine in asplenic patients. Eur J Clin Microbiol Infect Dis 30(5):611–618PubMedCrossRef
11.
go back to reference Meerveld-Eggink A, de Weerdt O, van Velzen-Blad H, Biesma DH, Rijkers GT (2011) Response to conjugate pneumococcal and Haemophilus influenzae type b vaccines in asplenic patients. Vaccine 29(4):675–680PubMedCrossRef Meerveld-Eggink A, de Weerdt O, van Velzen-Blad H, Biesma DH, Rijkers GT (2011) Response to conjugate pneumococcal and Haemophilus influenzae type b vaccines in asplenic patients. Vaccine 29(4):675–680PubMedCrossRef
12.
go back to reference World Health Organization (WHO) (2005) Recommendations for the production and control of pneumococcal conjugate vaccines. WHO Technical Report Series. WHO, Geneva, pp 64–98 World Health Organization (WHO) (2005) Recommendations for the production and control of pneumococcal conjugate vaccines. WHO Technical Report Series. WHO, Geneva, pp 64–98
13.
go back to reference Stanford E, Print F, Falconer M, Lamden K, Ghebrehewet S, Phin N, Baxter D, Helbert M, McCann R, Andrews N, Balmer P, Borrow R, Kaczmarski E (2009) Immune response to pneumococcal conjugate vaccination in asplenic individuals. Hum Vaccin 5(2):85–91PubMedCrossRef Stanford E, Print F, Falconer M, Lamden K, Ghebrehewet S, Phin N, Baxter D, Helbert M, McCann R, Andrews N, Balmer P, Borrow R, Kaczmarski E (2009) Immune response to pneumococcal conjugate vaccination in asplenic individuals. Hum Vaccin 5(2):85–91PubMedCrossRef
14.
go back to reference de Voer RM, van der Klis FR, Engels CW, Rijkers GT, Sanders EA, Berbers GA (2008) Development of a fluorescent-bead-based multiplex immunoassay to determine immunoglobulin G subclass responses to Neisseria meningitidis serogroup A and C polysaccharides. Clin Vaccine Immunol 15(8):1188–1193PubMedCrossRef de Voer RM, van der Klis FR, Engels CW, Rijkers GT, Sanders EA, Berbers GA (2008) Development of a fluorescent-bead-based multiplex immunoassay to determine immunoglobulin G subclass responses to Neisseria meningitidis serogroup A and C polysaccharides. Clin Vaccine Immunol 15(8):1188–1193PubMedCrossRef
15.
go back to reference Lal G, Balmer P, Joseph H, Dawson M, Borrow R (2004) Development and evaluation of a tetraplex flow cytometric assay for quantitation of serum antibodies to Neisseria meningitidis serogroups A, C, Y, and W-135. Clin Diagn Lab Immunol 11(2):272–279PubMed Lal G, Balmer P, Joseph H, Dawson M, Borrow R (2004) Development and evaluation of a tetraplex flow cytometric assay for quantitation of serum antibodies to Neisseria meningitidis serogroups A, C, Y, and W-135. Clin Diagn Lab Immunol 11(2):272–279PubMed
16.
go back to reference de Voer RM, Schepp RM, Versteegh FG, van der Klis FR, Berbers GA (2009) Simultaneous detection of Haemophilus influenzae type b polysaccharide-specific antibodies and Neisseria meningitidis serogroup A, C, Y, and W-135 polysaccharide-specific antibodies in a fluorescent-bead-based multiplex immunoassay. Clin Vaccine Immunol 16(3):433–436PubMedCrossRef de Voer RM, Schepp RM, Versteegh FG, van der Klis FR, Berbers GA (2009) Simultaneous detection of Haemophilus influenzae type b polysaccharide-specific antibodies and Neisseria meningitidis serogroup A, C, Y, and W-135 polysaccharide-specific antibodies in a fluorescent-bead-based multiplex immunoassay. Clin Vaccine Immunol 16(3):433–436PubMedCrossRef
17.
go back to reference Herrmann DJ, Hamilton RG, Barington T, Frasch CE, Arakere G, Mäkelä O, Mitchell LA, Nagel J, Rijkers GT, Zegers B, Danve B, Ward JI, Brown CS (1992) Quantitation of human IgG subclass antibodies to Haemophilus influenzae type b capsular polysaccharide. Results of an international collaborative study using enzyme immunoassay methodology. J Immunol Methods 148(1–2):101–114PubMedCrossRef Herrmann DJ, Hamilton RG, Barington T, Frasch CE, Arakere G, Mäkelä O, Mitchell LA, Nagel J, Rijkers GT, Zegers B, Danve B, Ward JI, Brown CS (1992) Quantitation of human IgG subclass antibodies to Haemophilus influenzae type b capsular polysaccharide. Results of an international collaborative study using enzyme immunoassay methodology. J Immunol Methods 148(1–2):101–114PubMedCrossRef
18.
go back to reference Käyhty H, Peltola H, Karanko V, Mäkelä PH (1983) The protective level of serum antibodies to the capsular polysaccharide of Haemophilus influenzae type b. J Infect Dis 147(6):1100PubMedCrossRef Käyhty H, Peltola H, Karanko V, Mäkelä PH (1983) The protective level of serum antibodies to the capsular polysaccharide of Haemophilus influenzae type b. J Infect Dis 147(6):1100PubMedCrossRef
19.
go back to reference Balmer P, Borrow R (2004) Serologic correlates of protection for evaluating the response to meningococcal vaccines. Expert Rev Vaccines 3(1):77–87PubMedCrossRef Balmer P, Borrow R (2004) Serologic correlates of protection for evaluating the response to meningococcal vaccines. Expert Rev Vaccines 3(1):77–87PubMedCrossRef
20.
go back to reference Ascherio A, Munger KL, Simon KC (2010) Vitamin D and multiple sclerosis. Lancet Neurol 9(6):599–612PubMedCrossRef Ascherio A, Munger KL, Simon KC (2010) Vitamin D and multiple sclerosis. Lancet Neurol 9(6):599–612PubMedCrossRef
21.
go back to reference Smolders J, Thewissen M, Peelen E, Menheere P, Cohen Tervaert JW, Damoiseaux J, Hupperts R (2009) Vitamin D status is positively correlated with regulatory T cell function in patients with multiple sclerosis. PLoS One 4(8):e6635PubMedCrossRef Smolders J, Thewissen M, Peelen E, Menheere P, Cohen Tervaert JW, Damoiseaux J, Hupperts R (2009) Vitamin D status is positively correlated with regulatory T cell function in patients with multiple sclerosis. PLoS One 4(8):e6635PubMedCrossRef
22.
go back to reference Smolders J, Peelen E, Thewissen M, Cohen Tervaert JW, Menheere P, Hupperts R, Damoiseaux J (2010) Safety and T cell modulating effects of high dose vitamin D3 supplementation in multiple sclerosis. PLoS One 5(12):e15235PubMedCrossRef Smolders J, Peelen E, Thewissen M, Cohen Tervaert JW, Menheere P, Hupperts R, Damoiseaux J (2010) Safety and T cell modulating effects of high dose vitamin D3 supplementation in multiple sclerosis. PLoS One 5(12):e15235PubMedCrossRef
23.
go back to reference Smolders J, Thewissen M, Theunissen R, Peelen E, Knippenberg S, Menheere P, Cohen Tervaert JW, Hupperts R, Damoiseaux J (2011) Vitamin D-related gene expression profiles in immune cells of patients with relapsing remitting multiple sclerosis. J Neuroimmunol 235(1–2):91–97PubMedCrossRef Smolders J, Thewissen M, Theunissen R, Peelen E, Knippenberg S, Menheere P, Cohen Tervaert JW, Hupperts R, Damoiseaux J (2011) Vitamin D-related gene expression profiles in immune cells of patients with relapsing remitting multiple sclerosis. J Neuroimmunol 235(1–2):91–97PubMedCrossRef
24.
go back to reference Chen S, Sims GP, Chen XX, Gu YY, Chen S, Lipsky PE (2007) Modulatory effects of 1,25-dihydroxyvitamin D3 on human B cell differentiation. J Immunol 179(3):1634–1647PubMed Chen S, Sims GP, Chen XX, Gu YY, Chen S, Lipsky PE (2007) Modulatory effects of 1,25-dihydroxyvitamin D3 on human B cell differentiation. J Immunol 179(3):1634–1647PubMed
25.
go back to reference Roth DE, Jones AB, Prosser C, Robinson JL, Vohra S (2009) Vitamin D status is not associated with the risk of hospitalization for acute bronchiolitis in early childhood. Eur J Clin Nutr 63(2):297–299PubMedCrossRef Roth DE, Jones AB, Prosser C, Robinson JL, Vohra S (2009) Vitamin D status is not associated with the risk of hospitalization for acute bronchiolitis in early childhood. Eur J Clin Nutr 63(2):297–299PubMedCrossRef
26.
go back to reference Ginde AA, Mansbach JM, Camargo CA Jr (2009) Association between serum 25-hydroxyvitamin D level and upper respiratory tract infection in the Third National Health and Nutrition Examination Survey. Arch Intern Med 169(4):384–390PubMedCrossRef Ginde AA, Mansbach JM, Camargo CA Jr (2009) Association between serum 25-hydroxyvitamin D level and upper respiratory tract infection in the Third National Health and Nutrition Examination Survey. Arch Intern Med 169(4):384–390PubMedCrossRef
27.
go back to reference Berry DJ, Hesketh K, Power C, Hyppönen E (2011) Vitamin D status has a linear association with seasonal infections and lung function in British adults. Br J Nutr 106(9):1433–1440PubMedCrossRef Berry DJ, Hesketh K, Power C, Hyppönen E (2011) Vitamin D status has a linear association with seasonal infections and lung function in British adults. Br J Nutr 106(9):1433–1440PubMedCrossRef
28.
go back to reference Laaksi I, Ruohola JP, Tuohimaa P, Auvinen A, Haataja R, Pihlajamäki H, Ylikomi T (2007) An association of serum vitamin D concentrations <40 nmol/L with acute respiratory tract infection in young Finnish men. Am J Clin Nutr 86(3):714–717PubMed Laaksi I, Ruohola JP, Tuohimaa P, Auvinen A, Haataja R, Pihlajamäki H, Ylikomi T (2007) An association of serum vitamin D concentrations <40 nmol/L with acute respiratory tract infection in young Finnish men. Am J Clin Nutr 86(3):714–717PubMed
29.
go back to reference Sabetta JR, DePetrillo P, Cipriani RJ, Smardin J, Burns LA, Landry ML (2010) Serum 25-hydroxyvitamin d and the incidence of acute viral respiratory tract infections in healthy adults. PLoS One 5(6):e11088PubMedCrossRef Sabetta JR, DePetrillo P, Cipriani RJ, Smardin J, Burns LA, Landry ML (2010) Serum 25-hydroxyvitamin d and the incidence of acute viral respiratory tract infections in healthy adults. PLoS One 5(6):e11088PubMedCrossRef
30.
go back to reference Laaksi I, Ruohola JP, Mattila V, Auvinen A, Ylikomi T, Pihlajamäki H (2010) Vitamin D supplementation for the prevention of acute respiratory tract infection: a randomized, double-blinded trial among young Finnish men. J Infect Dis 202(5):809–814PubMedCrossRef Laaksi I, Ruohola JP, Mattila V, Auvinen A, Ylikomi T, Pihlajamäki H (2010) Vitamin D supplementation for the prevention of acute respiratory tract infection: a randomized, double-blinded trial among young Finnish men. J Infect Dis 202(5):809–814PubMedCrossRef
31.
go back to reference Adams JS, Hewison M (2008) Unexpected actions of vitamin D: new perspectives on the regulation of innate and adaptive immunity. Nat Clin Pract Endocrinol Metab 4(2):80–90PubMedCrossRef Adams JS, Hewison M (2008) Unexpected actions of vitamin D: new perspectives on the regulation of innate and adaptive immunity. Nat Clin Pract Endocrinol Metab 4(2):80–90PubMedCrossRef
32.
go back to reference Chadha MK, Fakih M, Muindi J, Tian L, Mashtare T, Johnson CS, Trump D (2011) Effect of 25-hydroxyvitamin D status on serological response to influenza vaccine in prostate cancer patients. Prostate 71(4):368–372PubMedCrossRef Chadha MK, Fakih M, Muindi J, Tian L, Mashtare T, Johnson CS, Trump D (2011) Effect of 25-hydroxyvitamin D status on serological response to influenza vaccine in prostate cancer patients. Prostate 71(4):368–372PubMedCrossRef
33.
go back to reference Kriesel JD, Spruance J (1999) Calcitriol (1,25-dihydroxy-vitamin D3) coadministered with influenza vaccine does not enhance humoral immunity in human volunteers. Vaccine 17(15–16):1883–1888PubMedCrossRef Kriesel JD, Spruance J (1999) Calcitriol (1,25-dihydroxy-vitamin D3) coadministered with influenza vaccine does not enhance humoral immunity in human volunteers. Vaccine 17(15–16):1883–1888PubMedCrossRef
34.
go back to reference Heine G, Drozdenko G, Lahl A, Unterwalder N, Mei H, Volk HD, Dörner T, Radbruch A, Worm M (2011) Efficient tetanus toxoid immunization on vitamin D supplementation. Eur J Clin Nutr 65(3):329–334PubMedCrossRef Heine G, Drozdenko G, Lahl A, Unterwalder N, Mei H, Volk HD, Dörner T, Radbruch A, Worm M (2011) Efficient tetanus toxoid immunization on vitamin D supplementation. Eur J Clin Nutr 65(3):329–334PubMedCrossRef
35.
go back to reference Lee J, Zhao H, Fenta Y, Kita H, Kumar R, Juhn YJ (2011) Serum 25-hydroxyvitamin D is associated with enhanced pneumococcal antibody levels in individuals with asthma. Allergy Asthma Proc 32(6):445–452PubMedCrossRef Lee J, Zhao H, Fenta Y, Kita H, Kumar R, Juhn YJ (2011) Serum 25-hydroxyvitamin D is associated with enhanced pneumococcal antibody levels in individuals with asthma. Allergy Asthma Proc 32(6):445–452PubMedCrossRef
36.
go back to reference Defrance T, Taillardet M, Genestier L (2011) T cell-independent B cell memory. Curr Opin Immunol 23(3):330–336PubMedCrossRef Defrance T, Taillardet M, Genestier L (2011) T cell-independent B cell memory. Curr Opin Immunol 23(3):330–336PubMedCrossRef
37.
go back to reference Vieth R (2006) What is the optimal vitamin D status for health? Prog Biophys Mol Biol 92(1):26–32PubMedCrossRef Vieth R (2006) What is the optimal vitamin D status for health? Prog Biophys Mol Biol 92(1):26–32PubMedCrossRef
38.
go back to reference Sohl E, van Schoor NM, de Jongh RT, de Vries OJ, Lips P (2012) The impact of medication on vitamin D status in older individuals. Eur J Endocrinol 166(3):477–485PubMedCrossRef Sohl E, van Schoor NM, de Jongh RT, de Vries OJ, Lips P (2012) The impact of medication on vitamin D status in older individuals. Eur J Endocrinol 166(3):477–485PubMedCrossRef
39.
go back to reference van Dam RM, Snijder MB, Dekker JM, Stehouwer CD, Bouter LM, Heine RJ, Lips P (2007) Potentially modifiable determinants of vitamin D status in an older population in the Netherlands: the Hoorn Study. Am J Clin Nutr 85(3):755–761PubMed van Dam RM, Snijder MB, Dekker JM, Stehouwer CD, Bouter LM, Heine RJ, Lips P (2007) Potentially modifiable determinants of vitamin D status in an older population in the Netherlands: the Hoorn Study. Am J Clin Nutr 85(3):755–761PubMed
40.
go back to reference Smolders J, Hupperts R, Barkhof F, Grimaldi LM, Holmoy T, Killestein J, Rieckmann P, Schluep M, Vieth R, Hostalek U, Ghazi-Visser L, Beelke M; SOLAR study group (2011) Efficacy of vitamin D(3) as add-on therapy in patients with relapsing-remitting multiple sclerosis receiving subcutaneous interferon beta-1a: A Phase II, multicenter, double-blind, randomized, placebo-controlled trial. J Neurol Sci 311(1–2):44–49PubMedCrossRef Smolders J, Hupperts R, Barkhof F, Grimaldi LM, Holmoy T, Killestein J, Rieckmann P, Schluep M, Vieth R, Hostalek U, Ghazi-Visser L, Beelke M; SOLAR study group (2011) Efficacy of vitamin D(3) as add-on therapy in patients with relapsing-remitting multiple sclerosis receiving subcutaneous interferon beta-1a: A Phase II, multicenter, double-blind, randomized, placebo-controlled trial. J Neurol Sci 311(1–2):44–49PubMedCrossRef
Metadata
Title
Relatively high serum vitamin D levels do not impair the antibody response to encapsulated bacteria
Authors
E. Peelen
G. Rijkers
A. Meerveld-Eggink
S. Meijvis
M. Vogt
J. W. Cohen Tervaert
R. Hupperts
J. Damoiseaux
Publication date
01-01-2013
Publisher
Springer-Verlag
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 1/2013
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-012-1714-7

Other articles of this Issue 1/2013

European Journal of Clinical Microbiology & Infectious Diseases 1/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.